Bliss GVS Pharma

Historical price data

Bliss GVS Pharma is a revenue-generating, publicly traded pharmaceutical company with a vertically integrated model spanning API synthesis to finished dosage forms. Its core strategy leverages a dominant global position in suppository/pessary manufacturing and a diversified therapeutic portfolio to serve regulated, semi-regulated, and emerging markets. Key achievements include establishing a vast international commercial footprint and becoming a critical supplier of antimalarial therapies to global health initiatives.

Vertically integrated manufacturing platform with world-leading specialization in the complex production of suppositories and pessaries, coupled with expertise in API synthesis and formulation development for diverse dosage forms.

Competes with large Indian generics firms (e.g., Sun Pharma, Cipla) but holds a unique, defensible lead in suppository manufacturing. In anti-infectives, rivals other WHO-prequalified suppliers. Its competitive edge stems from vertical integration, niche specialization, and deep distribution networks in emerging markets.